{"title":"迟发性运动障碍。长期服用抗精神病药可能的并发症]。","authors":"F D'Aquila, L Rampello","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Tardive dyskinesia consists of abnormal involuntary movements at the oro-facial area (mouth, tongue, maxillary) or generalized choreoathetotic disorders of the limbs and trunk occurring in at least 10-20% of chronically neuropsychiatric patients exposed to neuroleptics. Age (over 50), gender (female), affective disorders, individual predisposition, type of drug, dosage and duration of neuroleptic exposure (over 3 months), anticholinergics, appear to be risk factors. In this brief review some current pathophysiological mechanisms and clinical therapeutical trials are also discussed.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"60 4","pages":"140-5"},"PeriodicalIF":0.0000,"publicationDate":"1990-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].\",\"authors\":\"F D'Aquila, L Rampello\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tardive dyskinesia consists of abnormal involuntary movements at the oro-facial area (mouth, tongue, maxillary) or generalized choreoathetotic disorders of the limbs and trunk occurring in at least 10-20% of chronically neuropsychiatric patients exposed to neuroleptics. Age (over 50), gender (female), affective disorders, individual predisposition, type of drug, dosage and duration of neuroleptic exposure (over 3 months), anticholinergics, appear to be risk factors. In this brief review some current pathophysiological mechanisms and clinical therapeutical trials are also discussed.</p>\",\"PeriodicalId\":76494,\"journal\":{\"name\":\"Rivista di neurologia\",\"volume\":\"60 4\",\"pages\":\"140-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rivista di neurologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rivista di neurologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
Tardive dyskinesia consists of abnormal involuntary movements at the oro-facial area (mouth, tongue, maxillary) or generalized choreoathetotic disorders of the limbs and trunk occurring in at least 10-20% of chronically neuropsychiatric patients exposed to neuroleptics. Age (over 50), gender (female), affective disorders, individual predisposition, type of drug, dosage and duration of neuroleptic exposure (over 3 months), anticholinergics, appear to be risk factors. In this brief review some current pathophysiological mechanisms and clinical therapeutical trials are also discussed.